valsartan has been researched along with Diabetic Feet in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-Moneim, RA; El-Salamouni, NS; Gowayed, MA; Kamel, MA; Labib, GS; Seiffein, NL | 1 |
1 other study(ies) available for valsartan and Diabetic Feet
Article | Year |
---|---|
Valsartan solid lipid nanoparticles integrated hydrogel: A challenging repurposed use in the treatment of diabetic foot ulcer, in-vitro/in-vivo experimental study.
Topics: Animals; Anti-Bacterial Agents; Diabetes Mellitus; Diabetic Foot; Drug Carriers; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogels; Lipids; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Valsartan; Vascular Endothelial Growth Factor A | 2021 |